BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11146553)

  • 1. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.
    Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Pérez-Mancera PA; Pintado B; Flores T; Battaner E; Sánchez-Garćia I
    Oncogene; 2000 Dec; 19(52):6015-22. PubMed ID: 11146553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice.
    Pérez-Mancera PA; Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Flores T; Battaner E; Gutiérrez-Adán A; Pintado B; Sánchez-García I
    Oncogene; 2002 Mar; 21(11):1679-84. PubMed ID: 11896599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice.
    Pérez-Losada J; Pintado B; Gutiérrez-Adán A; Flores T; Bañares-González B; del Campo JC; Martín-Martín JF; Battaner E; Sánchez-García I
    Oncogene; 2000 May; 19(20):2413-22. PubMed ID: 10828883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
    Kuroda M; Ishida T; Takanashi M; Satoh M; Machinami R; Watanabe T
    Am J Pathol; 1997 Sep; 151(3):735-44. PubMed ID: 9284822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
    Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
    Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
    Kanoe H; Nakayama T; Hosaka T; Murakami H; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Ron D; Sasaki MS; Toguchida J
    Oncogene; 1999 Jan; 18(3):721-9. PubMed ID: 9989822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
    Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
    Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat-specific FUS-DDIT3-transgenic mice establish PPARgamma inactivation is required to liposarcoma development.
    Pérez-Mancera PA; Vicente-Dueñas C; González-Herrero I; Sánchez-Martín M; Flores-Corral T; Sánchez-García I
    Carcinogenesis; 2007 Oct; 28(10):2069-73. PubMed ID: 17468515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications.
    Willeke F; Ridder R; Mechtersheimer G; Schwarzbach M; Duwe A; Weitz J; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Clin Cancer Res; 1998 Jul; 4(7):1779-84. PubMed ID: 9676855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
    Crozat A; Aman P; Mandahl N; Ron D
    Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
    Schwarzbach MH; Koesters R; Germann A; Mechtersheimer G; Geisbill J; Winkler S; Niedergethmann M; Ridder R; Buechler MW; von Knebel Doeberitz M; Willeke F
    Oncogene; 2004 Sep; 23(40):6798-805. PubMed ID: 15286712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
    Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
    Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma.
    Rivero ER; Mesquita RA; de Sousa SC; Nunes FD
    Ann Diagn Pathol; 2006 Feb; 10(1):36-8. PubMed ID: 16414544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel FUS/CHOP chimera in myxoid liposarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Mandahl N
    Biochem Biophys Res Commun; 2000 Dec; 279(3):838-45. PubMed ID: 11162437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.
    Rapp TB; Yang L; Conrad EU; Mandahl N; Chansky HA
    J Orthop Res; 2002 Jul; 20(4):723-9. PubMed ID: 12168660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
    Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
    Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.
    Panagopoulos I; Lassen C; Isaksson M; Mitelman F; Mandahl N; Aman P
    Oncogene; 1997 Sep; 15(11):1357-62. PubMed ID: 9315104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
    Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
    Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
    Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
    Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
    Prasad DD; Ouchida M; Lee L; Rao VN; Reddy ES
    Oncogene; 1994 Dec; 9(12):3717-29. PubMed ID: 7970732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.